Psychosocial management of patients with recurrent ovarian cancer: Treating the whole patient to improve quality of life

Seminars in Oncology Nursing

Volumn 19, Issue SUPPL. 1, 2003, Pages 40-53

  Fitch, Margaret I ^a  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALTRETAMINE; ANTIDEPRESSANT AGENT; ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; GEMCITABINE; PSYCHOSTIMULANT AGENT; TOPOTECAN;

ALOPECIA; ANXIETY; BODY IMAGE; CANCER RECURRENCE; CANCER SCREENING; CLINICAL EXAMINATION; CLINICAL PROTOCOL; CLINICAL TRIAL; COUNSELING; DAILY LIFE ACTIVITY; DEPRESSION; DIET RESTRICTION; DISEASE SEVERITY; DISTRESS SYNDROME; EMOTIONAL STABILITY; FAMILY; FATIGUE; FEMALE INFERTILITY; FINANCIAL MANAGEMENT; FRIEND; HAND FOOT SYNDROME; HEALTH CARE; HEALTH CARE COST; HEALTH EDUCATION; HUMAN; MEDICAL INFORMATION; MENOPAUSE; NAUSEA; OVARY CANCER; PAIN; PATIENT REFERRAL; PRACTICE GUIDELINE; PSYCHOSOCIAL DISORDER; QUALITY OF LIFE; RELIGION; REVIEW; SCORING SYSTEM; SEXUAL FUNCTION; SIDE EFFECT; SOCIAL INTERACTION; SOCIAL SUPPORT; STOMATITIS; TASTE DISORDER; VAGINAL DRYNESS; VOMITING; WEIGHT REDUCTION; WELLBEING; FEMALE; METHODOLOGY; NURSING; ONCOLOGY NURSING; OVARY TUMOR; PSYCHOLOGICAL ASPECT; SEXUALITY; TUMOR RECURRENCE;

FAMILY; FEMALE; HUMANS; NEOPLASM RECURRENCE, LOCAL; ONCOLOGIC NURSING; OVARIAN NEOPLASMS; QUALITY OF LIFE; SEXUALITY; SOCIAL SUPPORT;

EID: 15944373175     PISSN: 07492081     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-2081(03)00060-3     Document Type: Article

References (56)

1. Bodurka-Bevers D, Basen-Engquist K, Garmack CL, et al: Depression, anxiety, and quality of life in patients with epithelial ovarian cancer. Gynecol Oncol 78:302-308, 2000
2. Ersek M, Ferrell BR, Dow KH, Melancon CH: Quality of life in women with ovarian cancer. West J Nurs Res 19:334-350, 1997
3. Guidozzi F: Living with ovarian cancer. Gynecol Oncol 50:202-207, 1993
4. Kornblith AB, Thaler HT, Wong G, et al: Quality of life of women with ovarian cancer. Gynecol Oncol 59:231-242, 1995
5. Fitch M: Supportive care for cancer patients. Hosp Q 3:39-46, 2000
6. Nicholas DR, Veach TA: The psychosocial assessment of the adult cancer patient. Prof Psychol Res Pract 31:206-215, 2000
7. Davis CS, Zinkand JE, Fitch MI: Cancer treatment-induced menopause: Meaning for breast and gynecological cancer survivors. Can Oncol Nurs J 10:14-21, 2000
8. Steginga SK, Dunn J: Women's experiences following treatment for gynecologic cancer. Oncol Nurs Forum 24:1403-1408, 1997
9. Fitch M, Gray RE, Franssen E: Perspectives on living with ovarian cancer: Young women's views. Can Oncol Nurs J 10:101-108, 2000
10. Fitch MI, Gray RE, Franssen E: Perspectives on living with ovarian cancer: Older women's views. Oncol Nurs Forum 28:1433-1442, 2001
11. Fitch MI, Gray RE, Franssen E: Women's perspectives regarding the impact of ovarian cancer: Implications for nursing. Cancer Nurs 23:359-366, 2000
12. Powel LL: A closer look at psychosocial care. Oncol Nurs Forum 25:1677, 1998
13. Stead ML, Brown JM, Fallowfield L, et al: Communication about sexual problems and sexual concerns in ovarian cancer: A qualitative study. West J Med 176:18-19, 2002
14. Porzio G, Ruggeri B, Marchetti P, et al: Awareness of disease: A cross-sectional study on ovarian cancer patients. Proceedings of the 7th Biennial Meeting of the International Gynecologic Cancer Society, Rome, Italy, Sept 26-30, 1999. Monduzzi Editori, 1999, pp 281-284
15. Ruggeri B, Ballatori E, Casali P, et alAwareness of disease: A cross-sectional study on Italian cancer patients. Proceedings of the 7th Biennial Meeting of the International Gynecologic Cancer Society, Rome, Italy, Sept 26-30, 1999. Monduzzi Editori, 1999, pp S276 (abstr 1104)
16. Hamilton AB: Psychological aspects of ovarian cancer. Cancer Invest 17:335-341, 1999
17. Lammers SE, Schaefer KM, Ladd EC, et al: Caring for women living with ovarian cancer: Recommendations for advanced practice nurses. J Obstet Gynecol Neonatal Nurs 29:567-573, 2000
18. Collins JA: Tipping the balance: The WHI study and the benefits and risks of hormone replacement therapy. J Obstet Gynaecol Can 24:683-688, 2002
19. Lemay A: The relevance of the women's health initiative results on combined hormone replacement therapy in clinical practice. J Obstet Gynaecol Can 24:711-715, 2002
20. Kullmer U, Stenger K, Milch W, et al: Self-concept, body image, and use of unconventional therapies in patients with gynaecological malignancies in the state of complete remission and recurrence. Eur J Obstet Gynecol Reprod Biol 82:101-106, 1999
21. McGarvey EL, Baum LD, Pinkerton RG, et al: Psychological sequelae and alopecia among women with cancer. Cancer Pract 9:283-289, 2001
22. Münstedt K, Manthey N, Sachsse S, et al: Changes in self-concept and body image during alopecia induced cancer chemotherapy. Support Care Cancer 5:139-143, 1997
23. Montazeri A, McEwen J, Gillis CR: Quality of life in patients with ovarian cancer: Current state of research. Support Care Cancer 4:169-179, 1996
24. Gordon AN, Butler J: Chemotherapeutic management of advanced ovarian cancer. Semin Oncol Nurs 19:3-18, 2003 (suppl 1)
25. Gordon AN, Fleagle JT, Guthrie D, et al: Recurrent epithelial ovarian carcinoma: A randomized phase III study of pegylated liposomal doxorubicin versus topotecan. J Clin Oncol 19:3312-3322, 2001
26. Edwards SJ: Prevention and treatment of adverse effects related to chemotherapy for recurrent ovarian cancer. Semin Oncol Nurs 19:19-39, 2003 (suppl 1)
27. Portenoy RK, Thaler HT, Kornblith AB, et al: Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res 3:183-189, 1994
28. Wilmoth MC, Spinelli A: Sexual implications of gynecologic cancer treatments. J Obstet Gynecol Neonatal Nurs 29:413-421, 2000
29. Bachmann G: Physiologic aspects of natural and surgical menopause. J Reprod Med 46:307-315, 2001 (suppl)
30. Zacharias DR, Gilg CA, Foxall MJ: Quality of life and coping in patients with gynecologic cancer and their spouses. Oncol Nurs Forum 21:1699-1706, 1994
31. Portenoy RK, Kornblith AB, Wong G, et al: Pain in ovarian cancer patients. Prevalence, characteristics, and associated symptoms. Cancer 74:907-915, 1994
32. Curt GA, Breitbart W, Cella D, et al: Impact of cancer-related fatigue on the lives of patients: New findings from the Fatigue Coalition. Oncologist 5:353-360, 2000
33. Nail LM: Fatigue in patients with cancer. Oncol Nurs Forum 29:537-544, 2002
34. Gioiella ME, Berkman B, Robinson M: Spirituality and quality of life in gynecologic oncology patients. Cancer Pract 6:333-338, 1998
35. Bowes DE, Tamlyn D, Butler LJ: Women living with ovarian cancer: Dealing with an early death. Health Care Women Int 23:135-148, 2002
36. Smith ED, Stefanek ME, Joseph MV, et al: Spiritual awareness, personal perspective on death, and psychosocial distress among cancer patients: An initial investigation. J Psychosoc Oncol 11:89-103, 1993
37. Golberg B: Connection: An exploration of spirituality in nursing care. J Adv Nurs 27:836-842, 1998
38. McSherry W: Nurses' perceptions of spirituality and spiritual care. Nurs Stand 13:36-40, 1998
39. McSherry W, Draper P: The debates emerging from the literature surrounding the concept of spirituality as applied to nursing. J Adv Nurs 27:683-691, 1998
40. Latorre A, De Lena M, Catino A, et al: Epithelial ovarian cancer: Second and third line chemotherapy. Int J Oncol 21:179-186, 2002
41. Fitch M, Vachon M, Greenberg M, et al: Needs of cancer patients and their family members attending a comprehensive cancer care program. Proceedings of the 9th International Conference on Cancer Nursing, Brighton, England, Aug 12-16, 1996
42. The NCCN Distress Management Guideline. The Com-plete Library of NCCN Clinical Practice Guidelines in Oncology [CD-ROM]. Rockledge, Pennsylvania: National Comprehensive Cancer Network, May 2003. To view the most recent version of the guideline, go online to www.nccn.org
43. Patrick-Miller L, Much J, Axelrod A: Psychosocial distress screening of ambulatory oncology patients. Proc Am Soc Clin Oncol 21:380a, 2002 (abstr 1519)
44. Roth AJ, Kornblith AB, Batel-Copel L, et al: Rapid screening for psychologic distress in men with prostate carcinoma. A pilot study. Cancer 82:1904-1908, 1998
45. Zabora J, BrintzenhofeSzoc K, Jacobsen P, et al: A new psychosocial screening instrument for use with cancer patients. Psychosomatics 42:241-246, 2001
46. Zabora JR, Loscalzo M, Hibler M, et al: Implementation of distress management guidelines. Proc Am Soc Clin Oncol 21:247a, 2002 (abstr 984)
47. Cella DF, Tulsky DS, Gray G, et al: The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure. J Clin Oncol 11:570-579, 1993
48. National Cancer Institute: Normal adjustment, psychosocial distress, and the adjustment disorders (PDQ). July, 2002. Available at: http://cancer.gov/ cancerinfo/pdq/supportivecare/adjustment (accessed October 2002)
49. Annon JS. The Behavioural Treatment of Sexual Problems (vol 1): Brief Therapy. Hagerstown, MD, Harper & Row, 1976
50. Penson RT, Gallagher J, Gioiella ME, et al: Sexuality and cancer: conversation comfort zone. Oncologist 5:336-344, 2000
51. National Cancer Institute: Sexuality and reproductive issues (PDQ). Health professional version. September, 2002. Available at: http://cancer.gov/ cancerinfo/pdq/supportivecare/sexuality/healthprofessional (accessed October 2002)
52. Stewart DE, Wong F, Cheung AM, et al: Information needs and decisional preferences among women with ovarian cancer. Gynecol Oncol 77:357-361, 2000
53. Gray RE, Fitch M: Cancer self-help groups are here to stay: Issues and challenges for health professionals. J Palliat Care 17:53-58, 2001
54. Fitch MI, Gray RE, Greenberg M, et al: Self-help groups: oncology nurses' perspectives. Can Oncol Nurs J 11:76-81, 2001
55. Butow PN, Brown RF, Cogar S, et al: Oncologists' reactions to cancer patients' verbal cues. Psychooncology 11:47-58, 2002
56. Hack T, Pickles T, Bultz B, et al: Providing audiotapes of primary adjuvant treatment consultations to women with breast cancer: A multi-site randomized controlled trial. Proc Am Soc Clin Oncol 20:237a, 2001 (abstr 945)